Previous work from our lab has used the Dutch Ambulatory Monitoring System (AMS) to assess the cardiovascular responses and motility of large free-ranging species (e.g. horses). To further examine the utility of using the AMS with non-humans, a study investigating the heart rate (HR) and heart period variability (HRV) of a large canine undergoing behavioral modification therapy was undertaken. This treatment emulated a restraint and tactile pressure technique that has previously been used in horses. Cardiovascular responses and motility were continuously measured pre-treatment (exposure to a stimulus dog), during treatment (in-box), and post-treatment. The treatment consisted of placing the dog in a 110 cm (long) by 45 cm (wide) by 102 cm (height) wooden box that only covered the animals’ torso and legs and allowed the head to be free. Once the dog was in the box, the body was covered with a lightweight material (grain product) to effect restraint and tactile pressure, which was followed by a repeat exposure to the stimulus animal. Results indicated decreased heart rate and an increased HRV during the intervention as compared to baseline with indices of motility changing in the expected directions. Estimates of respiratory frequency derived from the autoregressive spectral analysis indicated changes in respiration did not account for the cardiovascular effects. In conclusion, tactile pressure and restraint may be an important tool for behavioral modification in both humans and animals, and the AMS is a useful tool for collecting cardiovascular data on a variety of species in a great many contexts.

Objective
Stress and its sequelae are very common in adults with autism spectrum disorder (ASD) without an intellectual disability (ID). Animal-assisted therapy (AAT) has shown physiological stress-reductive effects in children with ASD. The aim of the current study was to examine the acute psychophysiological response to an AAT session, and to examine the longer-term stress-physiological effects of the intervention, up until 10 weeks post-treatment, in comparison to waiting-list controls.
Method
A randomized controlled trial with pre-intervention (T0), post-intervention (T1: 10 weeks) and follow-up (T2: 20 weeks) measurements of neuroendocrine and cardiovascular measures, was conducted in 53 adults with ASD (N = 27 in intervention arm; N = 26 in control arm). Within the intervention group, stress-physiological data were collected during the 5th therapy session (acute effects). Data were analyzed with mixed models for outcome measures cortisol, alpha-amylase, heart rate variability and sympathetic activity.
Results
The AAT interventional session was significantly associated with reduced cortisol levels (β = −0.41, p = .010), while parasympathetic and sympathetic cardiovascular activity remained unaltered. No significant changes were found for stress-physiological measures at post-treatment time points.
Conclusions
Acute stress reduction, reflected in significant reduction in cortisol levels, was found during an AAT session in adults with ASD, without ID. More research is needed to explore to what extent the specific factors of AAT have contributed to the decrease in cortisol and whether stress reduction is possible for the longer-term.